| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |